![Jason Sawyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Sawyer
Directeur Général chez
GRIDAI TECHNOLOGIES CORP.
Fortune : 380 650 $ au 31/05/2026
Profil
Mr. Jason D.
Sawyer is a Chief Executive Officer & Director at GridAI Technologies Corp., an Independent Director at Lixte Biotechnology Holdings, Inc., an Independent Director at The FUTR Corp.
and a Head-Finance, Mergers & Acquisitions at Quantum BioPharma Ltd. He is on the Board of Directors at Greenland Mines Ltd., GridAI Technologies Corp., Lixte Biotechnology Holdings, Inc., The FUTR Corp., Caary Capital Ltd. and Perpetuals.com Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 40 000 ( 0,6 % ) | 224 400 $ | 31/05/2026 | |
| 15/04/2026 | 25 000 ( 0,2 % ) | 156 250 $ | 31/05/2026 | |
FUTR CORPORATION -.--% | 21/04/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jason Sawyer
| Sociétés | Poste | Début |
|---|---|---|
| THE FUTR CORPORATION | Directeur/Membre du Conseil | 17/06/2024 |
| GRIDAI TECHNOLOGIES CORP. | Directeur Général | 04/09/2025 |
| QUANTUM BIOPHARMA LTD. | Corporate Officer/Principal | - |
| LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Directeur/Membre du Conseil | 18/07/2025 |
| PERPETUALS.COM LTD | Directeur/Membre du Conseil | - |
Caary Capital Ltd.
 Caary Capital Ltd. Packaged SoftwareTechnology Services Develops automated accounting platform | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Lixte Biotechnology Holdings, Inc.
 Lixte Biotechnology Holdings, Inc. BiotechnologyHealth Technology Develops diagnostics, medication and treatments for various forms of cancer | Health Technology |
Entero Therapeutics, Inc.
 Entero Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures non-systemic therapies for the treatment of patients with gastrointestinal diseases | Health Technology |
FSD Pharma, Inc.
 FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
Earlyworks Co., Ltd.
 Earlyworks Co., Ltd. Packaged SoftwareTechnology Services Operates as a blockchain-based technology company | Technology Services |
Caary Capital Ltd.
Caary Capital Ltd. Packaged SoftwareTechnology Services Develops automated accounting platform | Technology Services |
Hank Payments Corp.
 Hank Payments Corp. Financial ConglomeratesFinance Operates financial technology software as a service platform company that automatically manages cash flow and debts with credits | Finance |
